meta|evidence COVID-19

Living systematic review and meta-analysis

adjuvant therapies
anti-inflammatoty and immuno-therapy
antiandrogenic
antiviral and associated therapy
chloroquine and derivatives
chloroquine
hydroxychloroquine
control
Drugs for acid related disorders
miscellaneous
Oral antidiabetic drugs
Renin-angiotensin-system-acting agents
vaccines
Vitamins

potential COVID-19 treatments
antiviral and associated therapy
lopinavir/ritonavir
control
placebo
standard of care

All
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
secondary prevention

Studies
Mapping
Meta-analysis
Excluded

Study		Exclusion reasons	Remarks	Reference(s)
Thakar, 2021	randomized controlled trial	other	chloroquine nasal drops	Thakar A Indian J Med Res 2021 Jan & Feb;153(1 & 2):151-158. 10.4103/ijmr.IJMR_3665_20

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -